Regenicin, Inc. Dilutive Securities, Effect on Basic Earnings Per Share
Regenicin, Inc. reported Dilutive Securities, Effect on Basic Earnings Per Share of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:DilutiveSecurities · last filed 2017-01-17
- Regenicin, Inc. dilutive securities, effect on basic earnings per share for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Regenicin, Inc. dilutive securities, effect on basic earnings per share for the quarter ending 2015-09-30 was $0.00.
- Regenicin, Inc. dilutive securities, effect on basic earnings per share for the quarter ending 2015-06-30 was $8.85M.
- Regenicin, Inc. dilutive securities, effect on basic earnings per share for the quarter ending 2015-03-31 was $8.85M.
- Regenicin, Inc. dilutive securities, effect on basic earnings per share for fiscal 2015 was $8.85M, a 80.00% decline from fiscal 2014.
- Regenicin, Inc. dilutive securities, effect on basic earnings per share for fiscal 2014 was $44.25M.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share 3 month | Dilutive Securities, Effect on Basic Earnings Per Share 6 month | Dilutive Securities, Effect on Basic Earnings Per Share 9 month | Dilutive Securities, Effect on Basic Earnings Per Share 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-23 | |||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-01-17 | $8.85M derived: sum of 2 quarters · filed 2017-01-17 | $17.70M derived: sum of 3 quarters · filed 2017-01-17 | $8.85M 10-K · filed 2017-01-17 |
| 2015-06-30 | $8.85M 10-Q · filed 2015-08-14 | $17.70M derived: sum of 2 quarters · filed 2016-05-23 | $8.85M 10-Q · filed 2016-08-22 | |
| 2015-03-31 | $8.85M 10-Q · filed 2016-05-23 | $8.85M 10-Q · filed 2016-05-23 | ||
| 2014-12-31 | $16.36M 10-Q · filed 2016-02-16 | |||
| 2014-09-30 | $44.25M 10-K · filed 2016-01-13 |